All posts by: Michael Zand

About Michael Zand

New cancer treatment ‘could replace chemotherapy in 10 years’, HKU expert claims – South China Morning Post

Continue reading

2017-10-02 NEWS

New cancer treatment ‘could replace chemotherapy in 10 years’, HKU expert claims
South China Morning Post
The immunotherapy was hailed as a global medical breakthrough three years ago and pharmaceutical companies around the world have been competing to develop immunotherapy drugs for different types of tumours. Such medications are expected to be on …

Continue reading

2017-10-01 NEWS

Immunotherapy Drugs Market share will Increase more than US$ 201.50 Billion by 2022
Medgadget (blog)
Market Research Engine has published a new report titled as “Immunotherapy Drugs Market By Type of Drugs Analysis (Monoclonal Antibodies, Adult Vaccines, Interferons Alpha & Beta, Interleukins, Checkpoint Inhibitors); By Therapy Area Analysis (Cancer, …

and more »

Continue reading

2017-10-01 NEWS

Futurism

A New Drug Uses CRISPR to Fight Antibiotic-Resistant Bacteria
Futurism
Eligo Bioscience believes the creation of eligobiotics — new smart drugs that attack harmful bacteria with precision — will be enough to combat antibiotic-resistant diseases and prevent the millions of deaths the infections are expected to cause in

Continue reading

2017-10-01 NEWS

MIMS General News (Hong Kong) (registration) (blog)

The much-adorned pioneer behind CRISPR/Cas9
MIMS General News (Hong Kong) (registration) (blog)
In 2015, he refined the technology to develop /Cas9-Cpf1; and in 2016, he founded CRISPR/C2c2 to target RNA. His ability to provide defining solutions appears to stem from his ability to mix together information from a multitude of areas. “When I’m